By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Imprimis Pharmaceuticals 

12264 El Camino Real
Suite 350
San Diego  California  92130-0001  U.S.A.
Phone: 858-704-4040 Fax: 858-345-1745


Key Statistics

Ownership: Public

Web Site: Imprimis
Symbol: immy

Company News
Imprimis (immy) Release: Peer-Reviewed Study Of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared To Drops 7/22/2016 12:20:17 PM
Imprimis (immy) To Present At 6th Annual LD Micro Invitational On June 8, 2016 6/3/2016 9:53:13 AM
Imprimis (immy) To Present At The Jefferies 2016 Healthcare Conference 6/1/2016 1:27:11 PM
Imprimis (immy) Announces First Quarter 2016 Financial Results And Provides Business Update 5/13/2016 6:29:29 AM
Clinical Study of Imprimis (immy)' Tri-Moxi-Vanc Dropless Therapy Formulation Show Statistically Significant Reduction In Cystoid Macular Edema In Patients Following Cataract Surgery 5/12/2016 6:59:39 AM
Imprimis (immy) Announces Plans To Launch IV Free Conscious Sedation And New Compounded Triple Drop Formulations At Leading Cataract And Refractive Surgeons Meeting 5/5/2016 8:00:31 AM
Imprimis (immy) To Host Its First Quarter 2016 Financial Report Conference Call And Webcast On May 12, 2016 At 4:30 P.M. EDT 5/4/2016 7:31:31 AM
Imprimis (immy) Begins Dispensing Lower Cost Alternative To Thiola 5/2/2016 9:18:07 AM
Imprimis (immy) Registers Its Texas Facility With The FDA As An Outsourcing Facility 4/12/2016 6:18:45 AM
Imprimis (immy) Announces Fourth Quarter And Year-End 2015 Financial Results And Provides Business Update 3/24/2016 6:49:14 AM